Physician profile
Sara Eapen
NPI 1962507301
$12,789.66
in general payments reported to CMS, 2019-2025
48 companies · $4,020 in 2025
The $4,020 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $189 · 2021: $470 · 2022: $1,822 · 2023: $2,675 · 2024: $3,128 · 2025: $4,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,822.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,984.42 | 2021-2025 | Linzess, Viberzi, Vraylar |
| Astrazeneca Pharmaceuticals Lp | $1,149.18 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $1,081.42 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $978.80 | 2019-2025 | |
| Novo Nordisk INC | $873.33 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $829.32 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $585.59 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $512.07 | 2022-2025 | |
| Astellas Pharma US INC | $452.41 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $378.48 | 2019-2025 | Otezla, Repatha, Evenity |
| Abbott Laboratories | $372.99 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Phathom Pharmaceuticals, INC. | $360.95 | 2024-2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $315.50 | 2023-2025 | Rexulti, Abilify Maintena |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $312.49 | 2021-2025 | Xifaxan |
| Exact Sciences Corporation | $254.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $190.58 | 2019-2025 | Eliquis |
| Ironwood Pharmaceuticals, INC | $182.97 | 2019-2025 | Linzess |
| Axsome Therapeutics, INC. | $138.33 | 2025 | Auvelity, Symbravo |
| Corcept Therapeutics | $131.49 | 2025 | Korlym |
| Teva Pharmaceuticals USA, INC. | $124.28 | 2021-2022 | |
| Vivus LLC | $119.65 | 2022-2025 | Qsymia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.96 | 2019-2025 | Jardiance, Tradjenta |
| Abiomed | $108.67 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.04 | 2025 | Trintellix |
| Xeris Pharmaceuticals, INC. | $106.01 | 2023-2024 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company Ltd. | $105.23 | 2022 | |
| Dexcom, INC. | $98.42 | 2022-2024 | Dexcom G6 Transmitter |
| Aimmune Therapeutics, INC. | $90.67 | 2024-2025 | Zenpep |
| Merck Sharp & Dohme LLC | $72.89 | 2020-2025 | Gardasil 9, Capvaxive, Varivax |
| Lundbeck LLC | $68.77 | 2023-2024 | Rexulti |
| Cranial Technologies, INC | $60.61 | 2019-2023 | Doc Band |
| Janssen Pharmaceuticals, INC | $57.67 | 2022-2025 | Spravato |
| Nestle Healthcare Nutrition INC. | $52.55 | 2023 | |
| Avanir Pharmaceuticals, INC. | $46.30 | 2019-2022 | |
| Currax Pharmaceuticals LLC | $42.72 | 2022-2025 | Contrave |
| Amarin Pharma, INC. | $39.94 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $36.11 | 2025 | Ultomiris |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.03 | 2022-2025 | Caplyta |
| Philips North America LLC | $34.84 | 2022 | |
| Evoke Pharma, INC. | $28.16 | 2022 | |
| Allergan, INC. | $25.91 | 2019-2020 | |
| Ucb, INC. | $24.13 | 2022 | |
| Supernus Pharmaceuticals, INC. | $20.38 | 2024 | Qelbree |
| Sanofi Pasteur INC. | $19.98 | 2019 | |
| Boston Scientific Corporation | $17.84 | 2025 | Wavewriter Alpha Prime 16 |
| Teleflex LLC | $16.85 | 2025 | Manta |
| Atricure, INC. | $15.36 | 2025 | Atriclip Laa Exclusion System |
| Lifescan, INC. | $14.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Eapen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.